alexinve

alexinve Updated 

Fundamental Analysis EBITDA: +7.2% YoY (to €990M in 2023) Margin: 11.8% (-0.2 points YoY) Net Income Group Share = 357 (+6.3% YoY) PER: 1680 / 357 = 4.71 (heavily undervalued considering below data and historical PERs) Net Gearing (Net Debt To Equity Ratio, ): 526/3462 = 0.15 (15%, Prudent) Total Debt To Equity Ratio: 5383 / 3462 = 1.55 (around 1 to 1.5 is...

alexinve

Heidelbergcement's future not looking good amid a raising interest rates environment for real estate promoters. Technical analysis: Bearish A Head and Shoulders pattern could be underway since Sep 2022 and once the stock has reached a double ceiling level at 77.50€. Besides, a Dark Cloud cover was formed on Friday 29th of September in the right shoulder and...

alexinve

This evening, Reuters published an article titled "AXA Weighs Offloading $2 Billion Reinsurance Arm to Cut Disaster Risk". Could this boost upwards tomorrow's and next days' share price after the US CPI reading?

alexinve Updated 

FUNDAMENTAL ANALYSIS Current liabilities increased 47% up to €3.4bn in 2022 from €2.3bn in 2021. Non-current liabilities decreased 37%. Debt to Equity ratio (2022) = 4.42x Debt to Equity ratio (2021) = 2.87x Losses YoY increased 133% to €522 million. EBITDA turned negative in 2022 to -€244 million from €52,672 million in 2021. Almost all Guidance provided in...

alexinve

After Job openings, JOLTS data and macroeconomic data weakening in US; a potential formation of Three Black Crows on Daily graph of Volkswagen could be underway jeopardising the last 6 positive candles. Tomorrow's closing candle will confirm if the Three Black Crows take place and next week we will see whether the prophecy ("sell") takes place.

alexinve

RECAP: Back in May 25, 2022, Nordex issued a profit warning and its stock was down -17.05%. The new estimates where: FY2022 PROFIT WARNING ESTIMATES FROM MAY 2022 (Source: Nordex's IR website section): – FY2022 Consolidated sales: EUR 5.2 to 5.7 billion – FY2022 EBITDA-margin: minus 4 to 0 percent, including all one-off effects - Capital expenditure: EUR 180...

alexinve

FUNDAMENTAL Very good fundamental results. Net debt to EBITDA ratio x0.99, EBITDA +35.6% increase YoY. Even though Canal+ business has Netflix and HBO as biggest competitors, Gameloft investment was a smartmove from Vivendi, as well as Lagardere. Deconsolidation of Telecom Italia damaged shareholders' attributable earnings up to -€1bn. I still need to get...

alexinve

Back in Oct 13, 2022 I made this analysis: Compared to Vonovia, Grand City has a double better debt position than its big competitor. Earnings payout are 23% and cash payout 64%. Vonovia's respective figures are 67% and 61%. Debt quity ratio at 57% is highly different from Vonovia's at 117%. Grand City may experiment higher costs of debt refinancing in 2023 but...

alexinve Updated 

After posting a more than 14% drop in 2022 operating profit (1.74bn), missing market estimates of 1.84 bn, and even though its operating capital generation (OCG) jumped 8% to 1.71 billion euros last year mainly thanks to higher interest rates and a strong business performance of the Netherlands Life and Insurance Europe segments; the company is shaping the biggest...

alexinve Updated 

The recent rally of Tesla could be unstoppable. At least, until $316.10 level. A formation of an inverse head and shoulders could be underway should inflation lay low next Tuesday 14th of February CPI reading. However, in the context of high tensions between China and the US and Russia and Europe; other variables may affect the market destroying any prediction...

alexinve Updated 

Bears in Twitter start to ask themselves whether they were all wrong or they were too early to bet against the market after the Fed was hawkish-but-not-too-hawkish in yesterday's meeting. DAX is a heavily automotive, banks and other cyclic assets weighted European index. Europe has performed better than America, but if ECB decides to implement an even more hawkish...

alexinve

FUNDAMENTAL AND TECHNICAL ANALYSIS FUNDAMENTAL 2022 EPS Q4 better than expected: 0.0503 (exp. 0.0388). Issued premiums revenue 5.895B (exp. 5.83B). Nevertheless, -36.1% YoY Q4 profits. Final dividend of 14.5 cents, payout 69.5%. Conclusion: weak 2022 results overall give the share price a PER of 8.83 at price 1.842. P of PER increases, an overvaluation could...

alexinve

After surpassing Fib 0.5, it looks like the stock is heading towards 0.382 level (21.81). Right now the company is immersed in a share repurchase program since 12/03/2021 and it has already acquired 19.23% of its €125 million valued shares objective. Maybe the company's financial advisers are playing with chart patterns in order to confirm its trend and go beyond...

alexinve Updated 

O2-Virgin operation in May. Before mid March, important date when competitors will provide information. Technical analysis shows a bullish bat pattern and its prophecy being accomplished today. Fibonacci retracement level 0.236 has been reached and tomorrow TEF may try to conquer 3.80 once again if profit taking doesn't make the stock flat all over the session....

alexinve Updated 

Sampo earnings results are due on Feb 11. H&S could be underway. Key support at 32.92, where I would say it would be a good moment to buy with the risk of losing 7.81% in the near term.

alexinve

-23% EBITDA YoY -62% Net Profits YoY -1% EBITDA QoQ (not that bad) The company expects €64M net profit in 2023, more than x5 than 2020. Short-term outlook bearish towards first support level at 3.71.

alexinve

TECHNICAL ANALYSIS RSI-14 is almost going under 30-level boundary (change in trend is expected once this happens, what means going from downward to upward trend) In the last week, sell volume has increased, specially on February 18 and 19. Key support at 5.55-5.65 Besides, SBS is closing a triangle which could foster some volatility in its...

alexinve

68.2% of GRIFOLS revenues come from the US and Canada. Covid19 cases there seem to be decreasing. The company is delaying more and more its deadline of results for the phase III of the inmunoglobulina antiCovid-19, now until spring 2021. If GRLS results are positive or better than expected (specially Q4 ones), I expect a jump from 21.61 to 26 in a matter of 2...